Clinical Trial Update: An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

Completed Phase 2 study evaluating 8- or 12-week regimens of simeprevir with sofosbuvir in treatment-naive and experienced adults with chronic hepatitis C genot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Simeprevir (simeprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED